start portlet menu bar end portlet menu bar

Vacunación en terneros - H. somni y M. Haemolytica

Inicio Conocimiento Vacunación en terneros - H. somni y M. Haemolytica

Vacunación en terneros - H. somni y M. Haemolytica

Since 2011, an action plan on the rational usage of antimicrobials has been implemented by the EU Commission (Cars 2014). Antibiotics are the main measure used for the control of respiratory problems in cattle, while vaccination could be an alternative. The aim of this study was to demonstrate the efficacy under field conditions of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) in reducing respiratory problems caused by these bacteria in cattle and in reducing the number of drug treatments.

Descarga este artículo

346 KB

Sobre este artículo

Autores

Foix, A.; Relancio, B.; March, R.

Resumen

The results of this study showed that vaccination with HIPRABOVIS® SOMNI/Lkt under field conditions produces a reduction in respiratory problems in calves based on the significant decrease in clinical respiratory signs and pneumonic lung lesions, as well as on the number of drug treatments. This vaccine would therefore enable the guidelines of the EU Commission to be followed by reducing antimicrobial use and improving the health status of the farm.

Productos relacionados

HIPRABOVIS® SOMNI/Lkt

Publicaciones relacionadas

Analysis of the antibodies induced by UBAC® vaccination Using HIPRABOVIS® SOMNI/LKT to control BRD in dairy calves: a field trial in Portugal Histophilus somni infection: an outbreak in cattle in Cental Italy

Compartir en

start portlet menu bar

Vacunación en terneros - H. somni y M. Haemolytica

Display portlet menu
end portlet menu bar

Ver también

Publicaciones

Serological response of calves vaccinated with 1 dose of a gE-/tk- deleted MLV IBR

01-10-2018
Post

Udder Health by HIPRA and CowSignals: 1 + 1 = 3

12-05-2017
Noticia

Nuevo Portal de Clientes de HIPRA

21-09-2018